Economic Costs of Lung Cancer in China
Shaoyu Fan, Mao Zheng-zhong, Lee Anita H, Hu Teh-wei
Abstract
Open-access reader
Shaoyu Fan, Mao Zheng-zhong, Lee Anita H, Hu Teh-wei
Abstract
Open-access reader
The economic costs of lung cancer include direct medical costs, direct non-medical costs, indirect morbidity costs, and indirect mortality costs. Indirect morbidity and mortality costs (loss of productivity to the society) are estimated using the human capital approach. Six cities in China were selected to represent the country's economic and geographic distribution.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The economic costs of lung cancer include direct medical costs, direct non-medical costs, indirect morbidity costs, and indirect mortality costs. Indirect morbidity and mortality costs (loss of productivity to the society) are estimated using the human capital approach. Six cities in China were selected to represent the country's economic and geographic distribution.
Key concepts: Indirect costs, China, Medical costs, Economic cost, Productivity, Lung cancer, Capital cost, Human capital